Whether it is a contractual issue or not is not particularly relevant. What is relevant is that under the direct sales model, NAN's profit margin will increase significantly.
- Forums
- ASX - By Stock
- NAN
- Direct sales strategy
Direct sales strategy, page-15
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.26 |
Change
-0.065(1.96%) |
Mkt cap ! $995.0M |
Open | High | Low | Value | Volume |
$3.31 | $3.31 | $3.21 | $293.4K | 89.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 1732 | $3.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.26 | 2419 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 1654 | 3.250 |
14 | 4465 | 3.240 |
10 | 5060 | 3.230 |
10 | 10044 | 3.220 |
9 | 5423 | 3.210 |
Price($) | Vol. | No. |
---|---|---|
3.260 | 2449 | 21 |
3.270 | 7019 | 15 |
3.280 | 10459 | 9 |
3.290 | 3391 | 8 |
3.300 | 32470 | 9 |
Last trade - 13.00pm 13/11/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online